TY - JOUR
T1 - Multicenter trial of transscleral diode laser retinopexy in retinal detachment surgery
AU - Haller, J. A.
AU - Blair, N.
AU - De Juan E., Jr
AU - De Bustros, S.
AU - Goldberg, M. F.
AU - Muldoon, T.
AU - Packo, K.
AU - Resnick, K.
AU - Rosen, R.
AU - Shapiro, M.
AU - Smiddy, W.
AU - Walsh, J.
PY - 1997
Y1 - 1997
N2 - Purpose: To evaluate the safety and efficacy of transscleral diode laser for retinopexy in rhegmatogenous retinal detachment surgery in a multicenter trial. Design: 67 patients with primary rhegmatogenous retinal detachment underwent scleral buckling surgery, using transscleral diode laser for retinopexy, at five study centers. Study Participants: 72 patients with primary rhegmatogenous retinal detachments were enrolled. No patient with chronic detachment, a retinal break greater than 90 degrees, history of uveitis or infectious retinopathy, or proliferative vitreoretinopathy was enrolled. Five eyes were excluded because they required additional nonprotocol treatment at the time of surgery (vitrectomy or supplementary cryotherapy due to probe malfunction). Main Outcome Measures: Retinal reattachment at six months after one operation. Secondary measures: visual acuity and complications, including choroidal, retinal, and vitreous hemorrhage, inflammation, and scleral damage.
AB - Purpose: To evaluate the safety and efficacy of transscleral diode laser for retinopexy in rhegmatogenous retinal detachment surgery in a multicenter trial. Design: 67 patients with primary rhegmatogenous retinal detachment underwent scleral buckling surgery, using transscleral diode laser for retinopexy, at five study centers. Study Participants: 72 patients with primary rhegmatogenous retinal detachments were enrolled. No patient with chronic detachment, a retinal break greater than 90 degrees, history of uveitis or infectious retinopathy, or proliferative vitreoretinopathy was enrolled. Five eyes were excluded because they required additional nonprotocol treatment at the time of surgery (vitrectomy or supplementary cryotherapy due to probe malfunction). Main Outcome Measures: Retinal reattachment at six months after one operation. Secondary measures: visual acuity and complications, including choroidal, retinal, and vitreous hemorrhage, inflammation, and scleral damage.
UR - http://www.scopus.com/inward/record.url?scp=0030694243&partnerID=8YFLogxK
M3 - Article
C2 - 9440171
AN - SCOPUS:0030694243
SN - 0065-9533
VL - 95
SP - 221
EP - 230
JO - Transactions of the American Ophthalmological Society
JF - Transactions of the American Ophthalmological Society
ER -